← Browse by Condition
Medical Condition
diabetic retinopathy
Total Trials
10
Recruiting Now
10
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for diabetic retinopathy sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — diabetic retinopathy Clinical Trials
How many clinical trials are currently recruiting for diabetic retinopathy?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for diabetic retinopathy, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for diabetic retinopathy?
diabetic retinopathy research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a diabetic retinopathy clinical trial?
Eligibility criteria for diabetic retinopathy trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06549023
Recruiting
Enrollment
40 pts
Location
Sweden
Sponsor
Vastra Gotaland Region
NCT03713268
Recruiting
Enrollment
262 pts
Location
United States
Sponsor
Duke University
NCT06782997
Recruiting
Enrollment
270 pts
Location
France
Sponsor
CHU de Reims
NCT03135327
Recruiting
Enrollment
5,000 pts
Location
United States
Sponsor
University of Miami
NCT06264427
Recruiting
Enrollment
1,000 pts
Location
Greenland
Sponsor
Steno Diabetes Center Greenlan...
NCT07338461
Recruiting
Enrollment
97 pts
Location
Italy
Sponsor
Heidelberg Engineering GmbH
NCT06763952
Recruiting
Enrollment
6,900 pts
Location
United States
Sponsor
University of Wisconsin, Madis...
NCT04547439 Phase 2
Recruiting
Enrollment
42 pts
Location
United States
Sponsor
University of Illinois Chicago
NCT05883072
Recruiting
Enrollment
300 pts
Location
Pakistan
Sponsor
Pakistan Council of Scientific...
NCT07236879
Recruiting
Enrollment
922 pts
Location
Brazil
Sponsor
Hospital de Clinicas de Porto ...
Related Conditions
diabetes mellitus type 2 (3) diabetes mellitus (2) proliferative diabetic retinopathy (1) diabetic retinopathy visually threatening (1) diabetic macular edema (1) diabetes mellitus type 1 (1) macular holes (1) epiretinal membrane (1) retinal detachment (1) retinal disease (1) preretinal fibrosis (1) cataract (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology